- Home
- SUPV vs HUMAW Comparison
SUPV vs HUMAW Comparison
Compare SUPV & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPV
- HUMAW
- Stock Information
- Founded
- SUPV 1887
- HUMAW 2004
- Country
- SUPV Argentina
- HUMAW United States
- Employees
- SUPV N/A
- HUMAW 220
- Industry
- SUPV Commercial Banks
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- SUPV Finance
- HUMAW Health Care
- Exchange
- SUPV Nasdaq
- HUMAW Nasdaq
- Market Cap
- SUPV N/A
- HUMAW N/A
- IPO Year
- SUPV 2016
- HUMAW N/A
- Fundamental
- Price
- SUPV $10.69
- HUMAW $0.49
- Analyst Decision
- SUPV Buy
- HUMAW
- Analyst Count
- SUPV 2
- HUMAW 0
- Target Price
- SUPV $17.00
- HUMAW N/A
- AVG Volume (30 Days)
- SUPV 1.3M
- HUMAW 14.2K
- Earning Date
- SUPV 08-13-2025
- HUMAW 03-21-2025
- Dividend Yield
- SUPV 1.89%
- HUMAW N/A
- EPS Growth
- SUPV N/A
- HUMAW N/A
- EPS
- SUPV 0.13
- HUMAW N/A
- Revenue
- SUPV $742,986,958.00
- HUMAW N/A
- Revenue This Year
- SUPV $49.61
- HUMAW N/A
- Revenue Next Year
- SUPV $37.60
- HUMAW N/A
- P/E Ratio
- SUPV $17.18
- HUMAW N/A
- Revenue Growth
- SUPV N/A
- HUMAW N/A
- 52 Week Low
- SUPV $5.00
- HUMAW $1.18
- 52 Week High
- SUPV $19.75
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- SUPV 29.14
- HUMAW N/A
- Support Level
- SUPV $10.87
- HUMAW N/A
- Resistance Level
- SUPV $12.78
- HUMAW N/A
- Average True Range (ATR)
- SUPV 0.58
- HUMAW 0.00
- MACD
- SUPV -0.14
- HUMAW 0.00
- Stochastic Oscillator
- SUPV 1.75
- HUMAW 0.00
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.